Abstract 1661: Preclinical characterization of XB773, a novel anti-DLL3 antibody-drug conjugate
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Exelixis (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148778346
Cites:
Cited by:
Related to:
